Evaluation of Transplant Renal Artery Stenosis by Contrast-Enhanced Ultrasonography: Comparison with Digital Subtraction Angiography
Transplantation Proceedings · 2026
DOI: 10.1016/j.transproceed.2025.12.013 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Transplantation Proceedings, 2026. Verfasst von Wenqi Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Angiography, Digital Subtraction, Renal Artery Obstruction, Contrast Media, Kidney Transplantation. Die Arbeit nennt 22 Literaturangaben. Gefördert von: Shanghai Municipal Health Commission, School of Medicine, Shanghai Jiao Tong University, National Natural Science Foundation of China.
Abstract (Originalsprache)
OBJECTIVE: Contrast-enhanced ultrasonography (CEUS) is a potential and safe imaging method to evaluate the transplant renal artery. To evaluate the degree and location of transplant renal artery stenosis (TRAS) by CEUS compared with digital subtraction angiography (DSA) as the reference standard. METHODS: This retrospective study included a cohort of 47 patients with TRAS who underwent ultrasound followed by DSA as the gold standard from March 2018 to January 2025. The degree and location of TRAS were evaluated using CEUS and were compared to that of DSA. Sensitivity, specificity, accuracy, positive predictive value (PPV) and negative predictive value (NPV) of CEUS for evaluating stenosis ≥50% and stenosis ≥70% were calculated. RESULTS: The diagnostic accuracy of CEUS in grading TRAS and diagnosing the location of TRAS was 83.8% and 97.3%, respectively. No significant differences were observed in assessing stenosis ≥50%, stenosis ≥70%, and the location of TRAS between CEUS and DSA (P = .250; P = .063; P = 1.000). There was a significant difference in grading TRAS between CEUS and DSA (P = .031). CEUS had a good performance in distinguishing stenosis ≥50% with a sensitivity of 91.4%, specificity of 100%, accuracy of 91.9%, PPV of 100%, and NPV of 40%. The sensitivity, specificity, accuracy, PPV, and NPV for the identification of stenosis ≥70% by CEUS were 87.1%, 100%, 89.2%, 100%, and 60%, respectively. CONCLUSION: CEUS demonstrates a great depiction of the degree and location in the TRAS compared with DSA. CEUS has the potential to be a noninvasive method to support the diagnosis and follow-up of TRAS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Ultrasound, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Urology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Ultrasound, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Electronic address: jinger_28@sina.com.
- Department of Ultrasound, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Electronic address: lihliwl@163.com.
Förderung
- Shanghai Municipal Health Commission
- School of Medicine, Shanghai Jiao Tong University
- National Natural Science Foundation of China
Zitieren
APA
Yang, W., Lai, Z., Cui, X., Zhong, C., Jiang, L., & Li, H. (2026). Evaluation of Transplant Renal Artery Stenosis by Contrast-Enhanced Ultrasonography: Comparison with Digital Subtraction Angiography. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2025.12.013
Vancouver
Yang W, Lai Z, Cui X, Zhong C, Jiang L, Li H. Evaluation of Transplant Renal Artery Stenosis by Contrast-Enhanced Ultrasonography: Comparison with Digital Subtraction Angiography. Transplantation Proceedings. 2026. doi:10.1016/j.transproceed.2025.12.013
BibTeX
@article{Yang2026,
author = {Yang, Wenqi and Lai, Zilong and Cui, Xiaolan and Zhong, Chen and Jiang, Lixin and Li, Hongli},
title = {Evaluation of Transplant Renal Artery Stenosis by Contrast-Enhanced Ultrasonography: Comparison with Digital Subtraction Angiography},
journal = {Transplantation Proceedings},
year = {2026},
doi = {10.1016/j.transproceed.2025.12.013}
}
EUVIMED